Mega Lifesciences PCL (BKK:MEGA-R) EV-to-EBIT : 8.82 (As of Jul. 17, 2025)

View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Mega Lifesciences PCL's Enterprise Value is ฿20,980 Mil. Mega Lifesciences PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ฿2,379 Mil. Therefore, Mega Lifesciences PCL's EV-to-EBIT for today is 8.82.

The historical rank and industry rank for Mega Lifesciences PCL's EV-to-EBIT or its related term are showing as below:

BKK:MEGA-R' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.65 Med: 17.51 Max: 31.6
Current: 8.82

During the past 13 years, the highest EV-to-EBIT of Mega Lifesciences PCL was 31.60. The lowest was 7.65. And the median was 17.51.

BKK:MEGA-R's EV-to-EBIT is ranked better than
81.7% of 683 companies
in the Drug Manufacturers industry
Industry Median: 17.81 vs BKK:MEGA-R: 8.82

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Mega Lifesciences PCL's Enterprise Value for the quarter that ended in Mar. 2025 was ฿23,659 Mil. Mega Lifesciences PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ฿2,379 Mil. Mega Lifesciences PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 10.06%.

Mega Lifesciences PCL EV-to-EBIT Historical Data

The historical data trend for Mega Lifesciences PCL's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Lifesciences PCL EV-to-EBIT Chart

Mega Lifesciences PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-EBIT

Get a 7-Day Free Trial

18.06

18.17

14.63

14.23

10.74

Mega Lifesciences PCL Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-EBIT	Get a 7-Day Free Trial															14.55	12.81	14.59	10.74	9.28

Competitive Comparison of Mega Lifesciences PCL's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Mega Lifesciences PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mega Lifesciences PCL's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mega Lifesciences PCL's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Mega Lifesciences PCL's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Mega Lifesciences PCL EV-to-EBIT Calculation

Mega Lifesciences PCL's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	20980.412	/	2379.01
	=	8.82

Mega Lifesciences PCL's current Enterprise Value is ฿20,980 Mil.
Mega Lifesciences PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿2,379 Mil.

Mega Lifesciences PCL (BKK:MEGA-R) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Mega Lifesciences PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 )	=	EBIT	/	Enterprise Value (Q: Mar. 2025 )
	=	2379.01	/	23658.5789538
	=	10.06 %

Mega Lifesciences PCL's Enterprise Value for the quarter that ended in Mar. 2025 was ฿23,659 Mil.
Mega Lifesciences PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿2,379 Mil.

Mega Lifesciences PCL EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Mega Lifesciences PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA-R) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

MEGA:Thailand

Address

Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea, Bangna, Bangkok, THA, 10260

Website

https://www.megawecare.com

Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL Headlines

No Headlines